Agenus - PDFSEARCH.IO - Document Search Engine

Agenus
Results: 10

#	Item
1	Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [removed] Add to Reading List Source URL: www.antigenics.com Language: English - Date: 2014-05-08 07:20:51 Medicine Anatomy Biotechnology Immune system Vaccine Virology Cancer vaccine Immunologic adjuvant Agenus Vaccination Immunology Biology
2	TERMS AND CONDITIONS OF USE Agenus Inc. is pleased to provide you with this website (“website”) and its content for general informational purposes. Please carefully read these Terms and Conditions relating to the use Add to Reading List Source URL: www.antigenics.com Language: English - Date: 2013-09-16 00:41:01 Severability Trademark Warranty Law of the United States Contractual term Defamation Implied warranty Copyright law of the United States South African contract law Law Contract law Private law
3	Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [removed] Add to Reading List Source URL: www.antigenics.com Language: English - Date: 2014-06-19 17:25:10 Vaccine Virology Agenus CD134 Forward-looking statement Biology Business law Microbiology Vaccination
4	Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications Add to Reading List Source URL: www.antigenics.com Language: English - Date: 2014-04-16 12:35:04 Vaccine Adjuvant Agenus Heat shock protein Vaccination Biology CD134
5	Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [removed] Add to Reading List Source URL: www.antigenics.com Language: English - Date: 2014-05-30 08:46:05 Vaccine CD134 Biology Forward-looking statement Vaccination Business law Agenus
6	Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [removed] Add to Reading List Source URL: www.agenusbio.com Language: English - Date: 2014-05-30 08:46:05 Vaccine CD134 Biology Forward-looking statement Vaccination Business law Agenus
7	Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications Add to Reading List Source URL: www.agenusbio.com Language: English - Date: 2014-04-16 12:35:04 Vaccine Adjuvant Agenus Heat shock protein Vaccination Biology CD134
8	Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [removed] Add to Reading List Source URL: www.agenusbio.com Language: English - Date: 2014-05-08 07:20:51 Medicine Anatomy Biotechnology Immune system Vaccine Virology Cancer vaccine Immunologic adjuvant Agenus Vaccination Immunology Biology
9	Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications [removed] Add to Reading List Source URL: www.agenusbio.com Language: English - Date: 2014-06-19 17:25:10 Vaccine Virology Agenus CD134 Forward-looking statement Biology Business law Microbiology Vaccination
10	TERMS AND CONDITIONS OF USE Agenus Inc. is pleased to provide you with this website (“website”) and its content for general informational purposes. Please carefully read these Terms and Conditions relating to the use Add to Reading List Source URL: www.agenusbio.com Language: English - Date: 2013-09-16 00:41:01 Severability Trademark Warranty Law of the United States Contractual term Defamation Implied warranty Copyright law of the United States South African contract law Law Contract law Private law

UPDATE